166 related articles for article (PubMed ID: 35389210)
21. An evolutionary, structural and functional overview of the mammalian TEAD1 and TEAD2 transcription factors.
Landin-Malt A; Benhaddou A; Zider A; Flagiello D
Gene; 2016 Oct; 591(1):292-303. PubMed ID: 27421669
[TBL] [Abstract][Full Text] [Related]
22. Comparative expression analysis of TEADs and their splice variants in mouse embryonic stem cells.
Cheng Y; Xiao Y; Ruan Y; Wang J; Tian Y; Xiong J; Wang J; Wang F; Zhang C; Xu Y; Liu L; Yu M; Wang J; Zhao B; Zhang Y; Yang R; Yang Y; Yao Z; Jian R; Xiao L; Zhang J
Gene Expr Patterns; 2023 Mar; 47():119302. PubMed ID: 36516960
[TBL] [Abstract][Full Text] [Related]
23. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
24. Discovery of a new class of reversible TEA domain transcription factor inhibitors with a novel binding mode.
Hu L; Sun Y; Liu S; Erb H; Singh A; Mao J; Luo X; Wu X
Elife; 2022 Nov; 11():. PubMed ID: 36398861
[TBL] [Abstract][Full Text] [Related]
25. TEAD family transcription factors in development and disease.
Currey L; Thor S; Piper M
Development; 2021 Jun; 148(12):. PubMed ID: 34128986
[TBL] [Abstract][Full Text] [Related]
26. Association of subcellular localization of TEAD transcription factors with outcome and progression in pancreatic ductal adenocarcinoma.
Drexler R; Fahy R; Küchler M; Wagner KC; Reese T; Ehmke M; Feyerabend B; Kleine M; Oldhafer KJ
Pancreatology; 2021 Jan; 21(1):170-179. PubMed ID: 33317954
[TBL] [Abstract][Full Text] [Related]
27. Lysine long-chain fatty acylation regulates the TEAD transcription factor.
Noritsugu K; Suzuki T; Dodo K; Ohgane K; Ichikawa Y; Koike K; Morita S; Umehara T; Ogawa K; Sodeoka M; Dohmae N; Yoshida M; Ito A
Cell Rep; 2023 Apr; 42(4):112388. PubMed ID: 37060904
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
29. A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunities.
Lou J; Lu Y; Cheng J; Zhou F; Yan Z; Zhang D; Meng X; Zhao Y
Eur J Med Chem; 2022 Dec; 243():114684. PubMed ID: 36063664
[TBL] [Abstract][Full Text] [Related]
30. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
Chai J; Xu S; Guo F
Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
[TBL] [Abstract][Full Text] [Related]
31. Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway.
Chan P; Han X; Zheng B; DeRan M; Yu J; Jarugumilli GK; Deng H; Pan D; Luo X; Wu X
Nat Chem Biol; 2016 Apr; 12(4):282-9. PubMed ID: 26900866
[TBL] [Abstract][Full Text] [Related]
32. TEAD Proteins Associate With DNA Repair Proteins to Facilitate Cellular Recovery From DNA Damage.
Calses PC; Pham VC; Guarnaccia AD; Choi M; Verschueren E; Bakker ST; Pham TH; Hinkle T; Liu C; Chang MT; Kljavin N; Bakalarski C; Haley B; Zou J; Yan C; Song X; Lin X; Rowntree R; Ashworth A; Dey A; Lill JR
Mol Cell Proteomics; 2023 Feb; 22(2):100496. PubMed ID: 36640924
[TBL] [Abstract][Full Text] [Related]
33. Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy.
Pobbati AV; Han X; Hung AW; Weiguang S; Huda N; Chen GY; Kang C; Chia CS; Luo X; Hong W; Poulsen A
Structure; 2015 Nov; 23(11):2076-86. PubMed ID: 26592798
[TBL] [Abstract][Full Text] [Related]
34. Tead transcription factors differentially regulate cortical development.
Mukhtar T; Breda J; Grison A; Karimaddini Z; Grobecker P; Iber D; Beisel C; van Nimwegen E; Taylor V
Sci Rep; 2020 Mar; 10(1):4625. PubMed ID: 32170161
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional analysis of the YAP-binding domain of human TEAD2.
Tian W; Yu J; Tomchick DR; Pan D; Luo X
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7293-8. PubMed ID: 20368466
[TBL] [Abstract][Full Text] [Related]
36. YAP/TAZ enhance mammalian embryonic neural stem cell characteristics in a Tead-dependent manner.
Han D; Byun SH; Park S; Kim J; Kim I; Ha S; Kwon M; Yoon K
Biochem Biophys Res Commun; 2015 Feb; 458(1):110-6. PubMed ID: 25634692
[TBL] [Abstract][Full Text] [Related]
37. Small-Molecule Cyanamide Pan-TEAD·YAP1 Covalent Antagonists.
Bum-Erdene K; Yeh IJ; Gonzalez-Gutierrez G; Ghozayel MK; Pollok K; Meroueh SO
J Med Chem; 2023 Jan; 66(1):266-284. PubMed ID: 36562717
[TBL] [Abstract][Full Text] [Related]
38. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation.
Chan SW; Lim CJ; Loo LS; Chong YF; Huang C; Hong W
J Biol Chem; 2009 May; 284(21):14347-58. PubMed ID: 19324876
[TBL] [Abstract][Full Text] [Related]
39. Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors.
Lu W; Wang J; Li Y; Tao H; Xiong H; Lian F; Gao J; Ma H; Lu T; Zhang D; Ye X; Ding H; Yue L; Zhang Y; Tang H; Zhang N; Yang Y; Jiang H; Chen K; Zhou B; Luo C
Eur J Med Chem; 2019 Dec; 184():111767. PubMed ID: 31622854
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors.
Holden JK; Cunningham CN
Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29558384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
